WaranteC's "WaranteC Implant Launch Show," held on June 11th and 12th in Ho Chi Minh City and Hanoi, Vietnam, successfully concluded with keen interest from the local dental community. Approximately 300 medical professionals and stakeholders attended the event, which showcased WaranteC's innovative implant technology and digital solutions.

WaranteC, a first-generation Korean implant brand, originated as part of the G7 Project in the 2000s, aiming to elevate South Korea to the level of advanced scientific and technological nations. It was established through 10 years of research and clinical trials with leading domestic dental schools, including Seoul National University, Yonsei University, and The Catholic University of Korea. Although previously known as part of the Yuhan Corporation Group, WaranteC became independent in September 2024 after Yuhan Corporation sold all its shares. Furthermore, WaranteC's technological prowess and growth potential were recognized when it attracted investment from global implant company Straumann in 2019. Its flagship products include IT implants, IU implants, and Oneplant for export. Recently, WaranteC has officially entered the digital dentistry market with the unveiling of its oral scanner, "Warantec IOS (WIOS)."

At the Vietnam launch show, Professor Jo Young-dan (Seoul National University School of Dentistry) and prominent Vietnamese speaker Tran Hung Lam were invited as main presenters. They shared successful immediate implant placement clinical cases using WaranteC implants and their practical application experiences. In particular, WaranteC's precise digital system, workflow, and implant surgical methods utilizing the WAGA kit were extensively introduced, garnering positive responses from attendees.

The dental implant market in Vietnam is considered a key market driving the growth of the Asia-Pacific implant market. It is projected to grow from an estimated $1.03 billion in 2019 to $1.48 billion in 2024, demonstrating a high compound annual growth rate of 7.52%. The Vietnamese government's increased investment in the healthcare sector, a growing elderly population and middle class, and rising health insurance enrollment continue to drive implant demand. Especially given that the market relies on imported medical devices for over 90% of its supply, the favorable environment for WaranteC is reinforced by the strong market share already held by Korean implants, such as Osstem and Dentium, which boast both quality and price competitiveness.

Following Vietnam, WaranteC accelerated its expansion into the Southeast Asian market by holding an implant launch event in Sri Lanka. The Sri Lanka event, themed "Tooth in Box," introduced a fast and accurate digital implant solution. Dr. Majed, WaranteC's Key Opinion Leader (KOL) in the Jordan region, attended to convey the technological expertise and extensive clinical experience of WaranteC implants.

Sim In-bo, CEO of WaranteC, emphasized the company's over 20 years of accumulated technology and clinically proven journey at the launch show, stating, "WaranteC has grown based on quality and trust as a first-generation Korean implant brand." He also declared that starting in the second half of 2025, opening new markets in Southeast Asia will be the top priority strategy, with Vietnam serving as a hub for more aggressive global expansion. A WaranteC official added that the company plans to increase market share by focusing on strengthening sales activities primarily with public hospitals in Sri Lanka and expanding its educational foundation through cooperation with local universities and educational sessions.

Through the launch shows in Vietnam and Sri Lanka, WaranteC successfully promoted its excellent implant technology and digital solutions, solidifying its position in the Southeast Asian market and laying the groundwork to become a leading company in the global dental market.

[Copyright (c) Global Economic Times. All Rights Reserved.]